Actigraphy devices market seen reaching $3.9 billion by 2030

The actigraphy devices market is projected to grow from $2.81 billion in 2026 to $3.9 billion by 2030, driven by rising sleep disorder cases, wearable technology adoption and digital health integration. North America led the market in 2025, while Asia-Pacific is expected to grow fastest over the forecast period.

Why it matters: - Actigraphy devices help clinicians track sleep and activity patterns without invasive procedures. - The market is expanding as sleep problems, remote monitoring and personalized sleep care become more common. - Demand is rising across hospitals, research settings and home-based monitoring.

What happened: - The Business Research Company released its Actigraphy Devices Market Report 2026, covering market size, trends and a global forecast through 2035. - The market was valued at $2.59 billion in 2025 and is projected to reach $2.81 billion in 2026. - The report forecasts the market will grow to $3.9 billion by 2030. - North America was the largest regional market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Actigraphy devices are wearable, non-invasive instruments that record physical activity and rest cycles over long periods. - The devices measure sleep-wake patterns and activity levels by detecting movement. - The data helps identify sleep disorders and assess circadian rhythm disruptions. - The 2026 growth estimate implies an 8.7% compound annual growth rate. - The 2030 forecast implies an 8.5% compound annual growth rate. - The report links past growth to higher sleep disorder prevalence, stronger awareness of circadian rhythm health, more sleep research, broader use of wearable health gadgets and demand for non-invasive diagnostics. - Future growth is expected to come from remote patient monitoring, deeper integration with digital health platforms, personalized sleep therapy, wider use in clinical trials and preventive sleep health management. - Key trends include adoption of wearable sleep trackers, actigraphy data in mobile health apps, long-term sleep monitoring, expansion of clinical and home monitoring, and better data precision and patient adherence. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report adds new strategic tools, including market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - A free sample is available here. - The full report is available here.

Between the lines: - The market forecast points to a shift from niche sleep tracking toward broader clinical and digital health use. - Rising sleep problems and mental health overlap may keep actigraphy relevant as a low-friction diagnostic and monitoring tool. - The emphasis on analytics, dashboards and company scoring suggests buyers want more than a size forecast; they want decision tools.

What's next: - The report expects wearable sleep tracking, remote monitoring and home-based care to expand further through 2030. - Asia-Pacific’s growth rate will be an important signal for suppliers and investors watching the next phase of market expansion. - Continued product improvement in accuracy and adherence could shape competitive positioning. - The broader market outlook through 2035 suggests more room for actigraphy in both consumer and clinical settings.